Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi
about
Update in Cystic Fibrosis 2014Noisy neighbourhoods: quorum sensing in fungal-polymicrobial infectionsAspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapyAnalysis of the chronic wound microbiota of 2,963 patients by 16S rDNA pyrosequencing.The Microbiome in Cystic Fibrosis.Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.Update on host-pathogen interactions in cystic fibrosis lung disease.Infection in cystic fibrosis: impact of the environment and climate.Cystic Fibrosis: Microbiology and Host ResponseMicrobiomes in respiratory health and disease: An Asia-Pacific perspective.An update on the pharmacotherapeutic management of lower respiratory tract infections.Susceptibility of Candida albicans from Cystic Fibrosis Patients.Ciprofloxacin dry powder inhaler in cystic fibrosis.Narrowing in on early cystic fibrosis lung disease.Bacterial infections in patients with primary ciliary dyskinesia: Comparison with cystic fibrosis.Nontuberculous Mycobacteria in Cystic Fibrosis.Positive Effect of Liposomal Amikacin for Inhalation on Mycobacterium abcessus in Cystic Fibrosis Patients.Lung colonization by Aspergillus fumigatus is controlled by ZNF77
P2860
Q22306307-E543EA0E-3BB7-4278-9510-A1D498470139Q26799027-D86FED06-639B-4DFC-8DCA-0033B621507FQ28074671-C90D6AD9-3124-4708-B43A-528724B62AD8Q35805594-114CC32C-FADF-47FB-8A18-5336CC3CDDD0Q35917770-5FE81B27-5C62-4128-95C7-D5F0FDF6F7EFQ36709312-1C5808B9-BF6D-4DDD-8642-61B2A0931742Q38605085-C091C77F-8FCD-4FCF-9092-165CEFE0F1A6Q38763542-1785E4B0-F25C-4244-8EBF-68BE69F1F4E6Q38911644-D0B5AFEF-243F-478B-A095-08183F0A471FQ39095070-AA6F918F-77A9-4B39-8DB8-EB418F0EE9C8Q40222424-042E707F-9805-4B6F-8AC3-1B72C35C52CBQ40245977-4A629179-84E6-4220-81E5-BE4814C6ED43Q40808977-B1DC9520-A163-4CA7-9774-487980C88072Q44790185-5B8F81ED-67B4-4F9C-B14F-44FD96AD2F67Q47097212-B1EC36AE-7C20-4393-BA28-2CEAC021378BQ52768051-4D79000D-5965-4306-B48E-5FA212924523Q53835921-667BF469-419C-4847-A474-C47C072FD405Q58712643-7B05AD63-FF3A-4EC7-9071-8158C82AEDB3
P2860
Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Antibiotic management of lung ...... anaerobic bacteria, and fungi
@ast
Antibiotic management of lung ...... anaerobic bacteria, and fungi
@en
type
label
Antibiotic management of lung ...... anaerobic bacteria, and fungi
@ast
Antibiotic management of lung ...... anaerobic bacteria, and fungi
@en
prefLabel
Antibiotic management of lung ...... anaerobic bacteria, and fungi
@ast
Antibiotic management of lung ...... anaerobic bacteria, and fungi
@en
P2093
P2860
P50
P1476
Antibiotic management of lung ...... anaerobic bacteria, and fungi
@en
P2093
Elliott C Dasenbrook
James F Chmiel
John J LiPuma
Sarath C Ranganathan
Timothy R Aksamit
Valerie J Waters
P2860
P304
P356
10.1513/ANNALSATS.201405-203AS
P577
2014-10-01T00:00:00Z